Literature DB >> 19204744

Forty years of anti-D immunoprophylaxis.

Giorgio Reali.   

Abstract

Year:  2007        PMID： 19204744      PMCID： PMC2535875          DOI： 10.2450/2007.0b18-06

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  13 in total

Review 1.  Molecular biology of partial D and weak D: implications for blood bank practice.

Authors:  Willy A Flegel; Franz F Wagner
Journal:  Clin Lab       Date:  2002       Impact factor: 1.138

Review 2.  Current status of immunoprophylaxis with anti-D immunoglobin.

Authors:  C P Engelfriet; H W Reesink; W J Judd; V-M Ulander; M Kuosmanen; S Koskinen; P Rouger; F Morelati; V Tantalo; T Fujii; M de Haas; C E van der Schoot; M Overbeeke; J Koelewijn; G Bonsel; T Vrijkotte; B Zupańska; C Martin-Vega; R Parra Lopez; M de Silva; M Contreras; S Panzer; B Ulm; W R Mayr
Journal:  Vox Sang       Date:  2003-11       Impact factor: 2.144

Review 3.  Oliver memorial lecture. Towards the conquest of Rh haemolytic disease: Britain's contribution and the role of serendipity.

Authors:  L A Tovey
Journal:  Transfus Med       Date:  1992-06       Impact factor: 2.019

4.  Experimental studies on the prevention of Rh haemolytic disease.

Authors:  R FINN; C A CLARKE; W T DONOHOE; R B McCONNELL; P M SHEPPARD; D LEHANE; W KULKE
Journal:  Br Med J       Date:  1961-05-27

5.  [Demonstration of fetal hemoglobin in erythrocytes of a blood smear].

Authors:  E KLEIHAUER; H BRAUN; K BETKE
Journal:  Klin Wochenschr       Date:  1957-06-15

6.  A survey of the current use of anti-D immunoprophylaxis and the incidence of haemolytic disease of the newborn in Italy.

Authors:  Claudio Velati
Journal:  Blood Transfus       Date:  2007-01       Impact factor: 3.443

7.  Treatment of Severe Erythroblastosis by Simultaneous Removal and Replacement of the Blood of the Newborn Infant.

Authors:  H Wallerstein
Journal:  Science       Date:  1946-05-10       Impact factor: 47.728

8.  Controlled trials of the treatment of haemolytic disease of the newborn.

Authors:  P L MOLLISON; W WALKER
Journal:  Lancet       Date:  1952-03-01       Impact factor: 79.321

Review 9.  Statement from the consensus conference on anti-D prophylaxis. 7 and 8 April 1997. The Royal College of Physicians of Edinburgh. The Royal College of Obstetricians and Gynaecologists, UK.

Authors: 
Journal:  Vox Sang       Date:  1998       Impact factor: 2.144

10.  Preventing rhesus babies: the Liverpool research and follow up.

Authors:  C A Clarke
Journal:  Arch Dis Child       Date:  1989-12       Impact factor: 3.791
View more
  6 in total

1.  Cytometry and Rhesus: not only for haemolytic disease of the newborn.

Authors:  Caterina Martini; Susanna Patroncini; Lorenzo Mighetto; Alessio Audino; Piera Girardi; Osvaldo Giachino; Giuseppe Natale
Journal:  Blood Transfus       Date:  2010-09-14       Impact factor: 3.443

2.  Survey on the prevention and incidence of haemolytic disease of the newborn in Italy.

Authors:  Francesco Bennardello; Giuseppe Curciarello
Journal:  Blood Transfus       Date:  2013-06-14       Impact factor: 3.443

3.  Antigen Density Dictates Immune Responsiveness following Red Blood Cell Transfusion.

Authors:  Connie M Arthur; Seema R Patel; Nicole H Smith; Ashley Bennett; Nourine A Kamili; Amanda Mener; Christian Gerner-Smidt; Harold C Sullivan; J Scott Hale; Andreas Wieland; Benjamin Youngblood; James C Zimring; Jeanne E Hendrickson; Sean R Stowell
Journal:  J Immunol       Date:  2017-03-01       Impact factor: 5.426

4.  Clinical value of different anti-D immunoglobulin strategies for preventing Rh hemolytic disease of the fetus and newborn: A network meta-analysis.

Authors:  Xiaohui Xie; Qiurong Fu; Ziwei Bao; Yi Zhang; Dan Zhou
Journal:  PLoS One       Date:  2020-03-12       Impact factor: 3.240

Review 5.  Fetal/Neonatal Alloimmune Thrombocytopenia: Pathogenesis, Diagnostics and Prevention.

Authors:  Ewa Brojer; Anne Husebekk; Marzena Dębska; Małgorzata Uhrynowska; Katarzyna Guz; Agnieszka Orzińska; Romuald Dębski; Krystyna Maślanka
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2015-11-12       Impact factor: 4.291

6.  Predicting anti-RhD titers in donors: Boostering response and decline rates are personal.

Authors:  Anneke S de Vos; C Ellen van der Schoot; Dimitris Rizopoulos; Mart P Janssen
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.